European Pharma Days
Join us for the European Pharma Days
Join Bruker for the annual European Pharma Meeting taking place on April 25th - 26th 2023 in Mannheim, Germany, organized by Bruker, M2Aind and CeMOS – Center for Mass Spectrometry and Optical Spectroscopy.
In this exciting 2-day in-person event we have speakers from the pharmaceutical industry and academia discussing with you their strategies in Drug Targeting Approaches (day 1) and Biomarker Discovery & Characterization (day 2).
Emerging topics in the field of Targeted Protein Degraders, SpatialOMx®, and MALDI Imaging will be presented by Bruker customers: we welcome Prof. Dr. Martina Marchetti-Deschmann (Technical University Vienna), Prof. Dr. Rob Vreeken (Janssen Pharmaceutica), Dr. Oliver Klein (BIH Center for Regenerative Therapies, Charité), Dr. Uli Ohmayer (NEOsphere), Dr. Nicolas Pythoud (Novartis), Dr. Yasemin Uçal, Dr. Alexandra Iakab (CeMOS), Dr. Stefan Linehan (TissueVision), and Stephane Chevrier (Navignostics) who will be presenting their state-of-the-art scientific research.
Curious about newest insights in the field of biomarker discovery with innovative proteomics, immunopeptidomics, metabolomics and lipidomics approaches? Then you cannot miss the presentations of Prof. Dr. Stefan Tenzer (University Medical Center Mainz), Dr. Carla Newman (GSK), Dr. Laura Bindila (University Medical Center Mainz), Dr. Jasjot Singh (Merck Group), Prof. Dr. Carsten Hopf (CeMOS), Dr. Marco Hennrich (GSK), Prof. Dr. Nicola Ternette (Oxford University), and Dr. Yuehan Feng (Biognosys).
The 2-day in-person event is held in a safe, comfortable environment where you can meet and learn from the leading scientist in the pharmaceutical industry and academia.
Reserve your free seat by clicking the registration link below.
Agenda
Day 1: Drug Targeting Approaches
Tuesday, April 25, 2023
10:00 - 11:00 Registration
11:00 - 11:10 Opening
Prof. Carsten Hopf, Ph.D., Head of Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany
Christian Albers, Ph.D., Business Development Manager, Pharmaceutical Markets, DACH, DK, Bruker Daltonics, Bremen, Germany
11:10 - 11:35 Molecules in Plain Sight – Studying Molecular Markers of Skin Aging
Prof. Martina Marchetti-Deschmann, Ph.D., TU Vienna, Austria
11:35 - 12:00 timsTOF Pro 2 for Targeted Protein Degradation (TPD)
Nicolas Pythoud, Ph.D., Senior Scientist Proteomics, Novartis, Basel, Switzerland
12:00 - 12:25 When the images are talking to us. Application of imaging mass spectrometry in clinical translational research
Oliver Klein, Ph.D., Imaging Mass Spectrometry Unit, BIH, Charité, Berlin, Germany
12:35 - 14:00 Lunch Break
14:00 - 14:25 The past, present and future of MSI at Janssen
Prof. Rob Vreeken, Ph.D., Head Discovery and Exploratory BA, Janssen Pharmaceutica, Beerse, Belgium, Associate Professor, M4I, Maastricht University, Netherlands
14:25 - 14:50 Spatial profiling in clinical samples using multimodal imaging
Yasemin Uçal, Ph.D., Post Doctoral Research Scientist, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany
14:50 - 15:15 Deep proteomic screening for systematic discovery and validation of degrader compounds and novel degrader target
Uli Ohmayer, Ph.D., Head of Mass Spectrometry, NEOsphere Biotechnologies, Planegg, Germany
15:15 - 15:45 Coffee Break
15:45 - 16:10 Current Advances in MALDI MSI-based Spatialomics
Stefania-Alexandra Iakab, Ph.D., Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany
16:10 - 16:35 Serial Two-Photon Plus: Translating ex vivo to in vivo imaging
Stefan Linehan, Ph.D., Vice President of Operations and Development, TissueVision, Boston, USA
16:35 - 17:00 Application of spatial single cell proteomics for patient stratification in clinical research
Stephane Chevrier, Ph.D., Co-founder, Navignostics, Zurich, Switzerland
17:00 - 18:00 Networking
Day 2: Biomarker Discovery
Wednesday, April 26, 2023
9:00 - 9:25 High sensitivity immunopeptidomics using Thunder-DDA-PASEF on the timsTOF Pro 2 and SCP platforms
Prof. Stefan Tenzer, Ph.D., Head of Mass Spectrometry Core Facility, University Medical Center Mainz, Germany
9:25 - 9:50 SuperM a combined targeted/untargeted high-throughput metabolomics platform for drug discovery
Marco Hennrich, Ph.D., Investigator, GSK, Heidelberg, Germany
9:50 - 10:15 4D-Lipidomic™ strategies for preclinical and clinical research
Laura Bindila, Ph.D., Head of Clinical Lipidomics Unit, University Medical Center Mainz, Germany
10:15 - 10:45 Coffee Break
10:45 - 11:10 Single Live-cell mass spectrometry (SiLC-MS) in the context of drug discovery
Carla Newman, Ph.D., Associate Director, Cellular Imaging and Dynamics, GSK, Stevenage, England
11:10 - 11:35 PreOmics and the BeatBox creating robust scalable workflows to process tissue and cells for proteomics
Russell Golson, Head of European Sales, PreOmics, UK
11:35 - 12:00 Proteomics applications to support drug development pipelines at Merck KGaA
Jasjot Singh, Ph.D., Senior Scientist Biomolecule Analytics, Merck KgaA, Darmstadt, Germany
12:00 - 13:30 Lunch Break
13:30 - 13:55 Highly sensitive tumour antigen discovery using the timsTOF SCP
Prof. Nicola Ternette, Ph.D., Associate Professor Antigen Discovery, Nuffield Department of Medicine, University of Oxford, United Kingdom
13:55 - 14:20 Class I and II neoantigen mapping in MSI-high colorectal cancer in needle biopsy size tissue samples
Yuehan Feng, Ph.D., Director, Scientific Alliances, Biognosys, Schlieren, Switzerland
14:20 - 14:45 Combining LC-MS lipidomics, metabolomics and MALDI Imaging in cancer research
Prof. Carsten Hopf, Ph.D., Head of Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany
14:45 - 15:00 Wrap-Up
For Research Use Only. Not for use in clinical diagnostic procedures.